Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations
Sneha Butala, Leslie Castelo‐Soccio, Rishi Seshadri, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 5, pp. 1361-1373
Open Access | Times Cited: 21

Showing 21 citing articles:

Recent Advancements in the Atopic Dermatitis Mechanism
Maria Savva, Nikolaos G. Papadopoulos, Stamatios Gregoriou, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 15
Treatable Traits in Asthma: The Importance of Extrapulmonary Traits—GERD, CRSwNP, Atopic Dermatitis, and Depression/Anxiety
Vanessa M. McDonald, Yuto Hamada, Àlvar Agustí, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 4, pp. 824-837
Closed Access | Times Cited: 8
Exploring the skin microbiome in atopic dermatitis pathogenesis and disease modification
Claudia Hülpüsch, Robin Rohayem, Matthias Reiger, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 1, pp. 31-41
Closed Access | Times Cited: 6
Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis
Motoshi Sonoda, Keishiro Kinoshita, Nobutaka Harada, et al.
Pediatric Rheumatology (2025) Vol. 23, Iss. 1
Open Access
Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights
Heidi M. Abdel-Mageed
Inflammopharmacology (2025)
Open Access
Comparative Real-World Analysis of Baseline Demographic Characteristics and Comorbidities in Atopic Dermatitis Patients Initiating Biologics Versus JAK Inhibitors
Álvaro Prados‐Carmona, F.J. Navarro‐Triviño, Husein Husein‐ElAhmed, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1291-1291
Open Access
Biologic and Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Mechanistic Considerations
Camille Rothenberg‐Lausell, Jonathan Bar, Dante Dahabreh, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 1, pp. 20-30
Closed Access | Times Cited: 4
Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study
Motohiro Ebisawa, Yoko Kataoka, Akio Tanaka, et al.
Allergology International (2024) Vol. 73, Iss. 4, pp. 532-542
Open Access | Times Cited: 1
Transdermal delivery of natural products against atopic dermatitis
Minghui Li, Yihua Xu, Yamei Yu, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 12, pp. 1076-1088
Closed Access | Times Cited: 1
Navigating the atopic dermatitis toolbox
Archana Samynathan, Jonathan I. Silverberg
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 3, pp. 337-343
Closed Access | Times Cited: 3
Challenging Best Practice of Atopic Dermatitis
Peter D. Arkwright, Jennifer J. Koplin
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 5, pp. 1391-1393
Open Access | Times Cited: 2
Kahweol Inhibits Pro-Inflammatory Cytokines and Chemokines in Tumor Necrosis Factor-α/Interferon-γ-Stimulated Human Keratinocyte HaCaT Cells
Ye Jin Kwon, Hyun Hee Kwon, Jaechan Leem, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3470-3483
Open Access
Revisiting immunotherapeutic strategies for the management of atopic dermatitis
Gaël Tchokomeni Siwe, Emmanuel Adebowale Fajemisin, Masala Mugeri, et al.
(2024), pp. 373-398
Open Access
The role of nemolizumab in the treatment of atopic dermatitis for the adult population
Stuti Prajapati, Joseph P Flemming, Danyaal Khan, et al.
Immunotherapy (2024) Vol. 16, Iss. 14-15, pp. 925-935
Closed Access
Oral Administration of Lactococcus lactis Expressing Mite and Cockroach Major Allergens Alleviates Progression of Atopic March in a Mouse Model
Mey-Fann Lee, Yi‐Hsing Chen, Chu-Hui Chiang, et al.
Allergy Asthma and Immunology Research (2024) Vol. 16, Iss. 5, pp. 520-520
Open Access
Development and Validation of Claims‐Based Algorithms for Conjunctivitis and Keratitis
Andrea K. Chomistek, Jessica M. Franklin, Rachel E. Sobel, et al.
Pharmacoepidemiology and Drug Safety (2024) Vol. 33, Iss. 11
Open Access
Resolution of Chronic Inflammation, Restoration of Epigenetic Disturbances and Correction of Dysbiosis as an Adjunctive Approach to the Treatment of Atopic Dermatitis
Gregory Livshits, Alexander Kalinkovich
Cells (2024) Vol. 13, Iss. 22, pp. 1899-1899
Open Access
Worldwide prevalence of atopic dermatitis in children between 2000 and 2021: a systematic analysis
Ling Jin, Jian Ge, Ying Cheng, et al.
Annals of Allergy Asthma & Immunology (2024)
Closed Access
A practical approach to caring for atopic dermatitis in children
Diana K. Bayer
Current Opinion in Pediatrics (2023) Vol. 35, Iss. 6, pp. 686-691
Closed Access | Times Cited: 1
Justification of the efficacy of combined therapy with dupilumab and cyclosporine in children with severe dermato-respiratory syndrome
Rami Yu. Aoun, V.Yu. Udzhukhu, С. В. Кукало, et al.
Russian Journal of Skin and Venereal Diseases (2023) Vol. 26, Iss. 3, pp. 307-314
Open Access
Levels of eosinophils and interleukin-5 and severity of atopic dermatitis in the presence of psychosocial stress
A. S. Prilutskiy, Yuliya A. Lygina
Russian Journal of Allergy (2023) Vol. 20, Iss. 4, pp. 415-428
Closed Access
Page 1

Scroll to top